TrialClinical pharmacokinetics2016

Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects.

Takayuki Katsube et al.PubMed ↗Publisher ↗

No numbers read from the abstract.